Agilent Technologies Inc (A)vsAdaptive Biotechnologies Corp (ADPT)
A
Agilent Technologies Inc
$146.93
+2.66%
HEALTHCARE · Cap: $41.41B
ADPT
Adaptive Biotechnologies Corp
$24.20
-0.12%
HEALTHCARE · Cap: $3.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Agilent Technologies Inc generates 2293% more annual revenue ($7.37B vs $308.08M). A leads profitability with a 19.5% profit margin vs -20.7%. A earns a higher WallStSmart Score of 63/100 (C+).
A
Buy63
out of 100
Grade: C+
ADPT
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-66.4%
Fair Value
$77.48
Current Price
$146.93
$69.45 premium
Margin of Safety
+51.0%
Fair Value
$31.91
Current Price
$24.20
$7.71 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 25.6%
Revenue surging 21.5% year-over-year
Areas to Watch
Moderate valuation
Grey zone — moderate risk
Weak financial health signals
0.0% earnings growth
Trading at 26.9x book value
ROE of -23.0% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.25 suggests the stock is reasonably priced for its growth.
Bull Case : ADPT
The strongest argument for ADPT centers on Revenue Growth. Revenue growth of 21.5% demonstrates continued momentum.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : ADPT
The primary concerns for ADPT are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 2.87 is elevated, increasing financial risk.
Key Dynamics to Monitor
A profiles as a mature stock while ADPT is a growth play — different risk/reward profiles.
ADPT carries more volatility with a beta of 2.10 — expect wider price swings.
ADPT is growing revenue faster at 21.5% — sustainability is the question.
A generates stronger free cash flow (439M), providing more financial flexibility.
Bottom Line
A scores higher overall (63/100 vs 28/100), backed by strong 19.5% margins. ADPT offers better value entry with a 51.0% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Adaptive Biotechnologies Corp
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.
Visit Website →Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?